Researchers have released details of a breakthrough which holds promise of a new therapeutic approach for the treatment of Duchenne muscular dystrophy (DMD), an incurable muscle-wasting disease. The research has demonstrated that a process known as exon skipping has shown dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.